Clinical Trials and Translational Research in Stroke
This session will examine clinical trials and translational research in stroke treatment and prevention, highlighting innovative therapies, trial design, and evidence-based practice. Discussions will explore phase I-IV trials, regulatory considerations, and patient recruitment strategies aimed at advancing therapeutic interventions and biomarker discovery in stroke care. The session will showcase bench-to-bedside approaches and proof-of-concept studies that bridge the gap between basic science discoveries and clinical applications in stroke medicine. By fostering dialogue among clinical investigators, research sponsors, and regulatory agencies, this session aims to promote rigorous research standards, ethical conduct, and data transparency in stroke clinical trials, ultimately translating scientific discoveries into tangible benefits for patients and caregivers.